Standard Biotools (LAB) EBITDA Margin (2010 - 2026)
Standard Biotools (LAB) posted quarterly EBITDA Margin of 59.09% for Q1 2026, up 7428.0% year-over-year from 0.78% in Q1 2025, and up 42.94% quarter-over-quarter from 103.57% in Q4 2025.
Standard Biotools (LAB) EBITDA Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported EBITDA Margin for 17 consecutive years, with 59.09% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 7428.0% year-over-year to 59.09%; the TTM figure through Mar 2026 stood at 111.04% (up 1178.0% YoY), while the FY2025 annual figure was 129.2%, up 1088.0% from the prior year.
- EBITDA Margin climbed to 59.09% in Q1 2026 per LAB's latest filing, from 103.57% in the prior quarter.
- Across five years, EBITDA Margin topped out at 59.09% in Q1 2026 and bottomed at 205.37% in Q2 2022.
- Historically, EBITDA Margin has averaged 109.67% across 5 years, with a median of 105.27% in 2024.
- Annual changes were most pronounced in 2022 — EBITDA Margin slumped 14804 bps — and 2023, when it jumped 14230 bps.
- Standard Biotools' EBITDA Margin stood at 78.13% in 2022, then advanced by 3 bps to 75.87% in 2023, then plunged by 39 bps to 105.27% in 2024, then climbed by 2 bps to 103.57% in 2025, then soared by 43 bps to 59.09% in 2026.
- Business Quant data shows LAB's EBITDA Margin at 59.09% in Q1 2026, 103.57% in Q4 2025, and 168.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 19.15% |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | -126.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -126.28% |
| Mar 31, 2026 | -59.09% |
| Dec 31, 2025 | -103.57% |
| Sep 30, 2025 | -168.46% |
| Jun 30, 2025 | -118.08% |
| Mar 31, 2025 | -133.37% |
| Dec 31, 2024 | -105.27% |
| Sep 30, 2024 | -120.89% |
| Jun 30, 2024 | -134.54% |
| Mar 31, 2024 | -132.15% |
| Dec 31, 2023 | -75.87% |
| Sep 30, 2023 | -83.46% |
| Jun 30, 2023 | -63.07% |
| Mar 31, 2023 | -66.06% |
| Dec 31, 2022 | -78.13% |
| Sep 30, 2022 | -113.18% |
| Jun 30, 2022 | -205.37% |
| Mar 31, 2022 | -103.77% |
| Sep 30, 2021 | -60.88% |
| Jun 30, 2021 | -57.34% |